Overview

U.S. Gynecology Robotic Surgery Market is poised to value over USD 1.3 billion by 2027 end at a CAGR of over 6.5% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of U.S. Gynecology Robotic Surgery Market trend that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the U.S. Gynecology Robotic Surgery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the U.S. Gynecology Robotic Surgery Market:
• Intuitive Surgical, Inc.
• TransEnterix Surgical, Inc.
• Medrobotics Corporation
• Titan Medical Inc.
• CMR Surgical Limited
• Avateramedical GmbH
• Medtronic
• Verb Surgical, Inc
• Olympus Corporation
• Stryker
(Note: The list of the major players will be updated with the latest market scenario and trends)

U.S. Gynecology Robotic Surgery Market Segmentation:
By Product Type
• Robotic Systems
• Instruments & Accessories
• Services

By End User
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Physician’s Offices

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the U.S. Gynecology Robotic Surgery Market By Product Type and By End User.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions—U.S.  
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customisation offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. U.S. Gynecology Robotic Surgery Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Product Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. U.S. Gynecology Robotic Surgery Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Product Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Product Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. U.S. Gynecology Robotic Surgery Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Robotic Systems
  7.2. Instruments & Accessories
  7.3. Services

8. U.S. Gynecology Robotic Surgery Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Hospitals and Clinics
  8.2. Ambulatory Surgical Centers
  8.3. Physician’s Offices

9. Market Share Analysis and Competitive Landscape  
  9.1. U.S. Landscape - Key Players, Revenue and Presence
  9.2. U.S. Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  9.3. U.S. Emerging Companies
  9.4. U.S. Key Player - Growth Matrix

10. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   10.1. Intuitive Surgical, Inc.
         10.1.1. Company Overview
         10.1.2. Product Portfolio
         10.1.3. SWOT Analysis
         10.1.4. Financial Overview
         10.1.5. Strategic Overview
   10.2. TransEnterix Surgical, Inc.
         10.2.1. Company Overview
         10.2.2. Product Portfolio
         10.2.3. SWOT Analysis
         10.2.4. Financial Overview
         10.2.5. Strategic Overview
   10.3. Medrobotics Corporation
         10.3.1. Company Overview
         10.3.2. Product Portfolio
         10.3.3. SWOT Analysis
         10.3.4. Financial Overview
         10.3.5. Strategic Overview
   10.4.   Titan Medical Inc.
         10.4.1. Company Overview
         10.4.2. Product Portfolio
         10.4.3. SWOT Analysis
         10.4.4. Financial Overview
         10.4.5. Strategic Overview
   10.5. CMR Surgical Limited
         10.5.1. Company Overview
         10.5.2. Product Portfolio
         10.5.3. SWOT Analysis
         10.5.4. Financial Overview
         10.5.5. Strategic Overview          
   10.6. Avateramedical GmbH
         10.6.1. Company Overview
         10.6.2. Product Portfolio
         10.6.3. SWOT Analysis
         10.6.4. Financial Overview
         10.6.5. Strategic Overview      
   10.7. Medtronic
         10.7.1. Company Overview
         10.7.2. Product Portfolio
         10.7.3. SWOT Analysis
         10.7.4. Financial Overview
         10.7.5. Strategic Overview
   10.8. Verb Surgical, Inc
         10.8.1. Company Overview
         10.8.2. Product Portfolio
         10.8.3. SWOT Analysis
         10.8.4. Financial Overview
         10.8.5. Strategic Overview
   10.9. Olympus Corporation
         10.9.1. Company Overview
         10.9.2. Product Portfolio
         10.9.3. SWOT Analysis
         10.9.4. Financial Overview
         10.9.5. Strategic Overview
   10.10.Stryker
         10.10.1. Company Overview
         10.10.2. Product Portfolio
         10.10.3. SWOT Analysis
         10.10.4. Financial Overview
         10.10.5. Strategic Overview

11. Pre and Post COVID-19 Impact
   11.1. Positive influence on the healthcare industry
   11.2. The financial disruption of the manufacturing sector
   11.3. Impact of COVID-19 on emerging companies
   11.4. Significant mandates in the healthcare regulations initiated by administrations
   11.5. The overall economic slowdown of the developing and developed nations

12. FutureWise SME Key Takeaway Points for Client

Tables

Figures